期刊文献+

消减免疫法在单克隆抗体制备中的应用

Application of Subtractive Immunization in Preparing Monoclonal Antibody
下载PDF
导出
摘要 单克隆抗体是现代生命科学研究的重要工具。常规的杂交瘤技术通常并不能获得特定目的抗原的单克隆抗体,而消减免疫法可在一定程度上弥补这一缺陷。消减免疫利用特殊的免疫耐受途径来大幅增加目的单抗的产生数目。它建立在宿主动物对免疫显性抗原或非目的抗原(耐受原)耐受的基础上,宿主动物可通过高区带耐受、新生期耐受和药物介导的耐受等3种方法获得耐受,然后再对已耐受的动物接种目的抗原(免疫原),特异性抗体便随之产生。近20年来,用消减免疫法成功地制备了多种独特抗体。简要阐述了可用消减免疫法获得的单克隆抗体的制备。 Monoclonal antibodies are very important tools in modern life science research. However, standard immunization approaches frequently fail to provide monoclonal antibodies with the desired specificity. Subtractive immunization provides a powerful alternative to standard immunization. Subtractive immunization utilizes a distinct immune tolerization approach that can substantially enhance the generation of monoclonal antibodies to desired antigens. The approach is based on tolerizing the host animal to immunodominant or otherwise undesired antigen(tolerogen). Tolerization of the host animal can be achieved through one of three methods: high zone, neonatal or drng-induced tolerization. The tolefized animal is then inoculated with the desired antigen (immunogen) and antibodies generated by the subsequent immune response are screened for the desired antigenic reactivity. Over the past 20 years a large number of investigators have used the subtractive approach successfully generated uniquely reactive antibodies. This review focused on the implementation of subtractive immunization for the production of antibodies unobtainable by standard immunization.
出处 《生物技术通讯》 CAS 2008年第5期754-756,共3页 Letters in Biotechnology
基金 国家高技术研究发展计划(2006AA06Z408)
关键词 消减免疫 高区带耐受 新生期耐受 药物介导的耐受 subtractive immunization high zone tolerization neonatal tolerization drug-induced tolerization
  • 相关文献

参考文献26

  • 1Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined sepecificity[J]. Nature, 1975,256:495-497.
  • 2Hooper J D, Zijlstra A, Aimes R T, et al. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen[J]. Oncogene, 2003,22:1783-1794.
  • 3Joshi S A, Ranpura S A, Khan S A, et al. Monoclonal antibodies to epididymis-specific proteins using mice rendered immune tolerant to testicular proteins[J]. J Androl, 2003,24:524-533.
  • 4Sleister H M, Rao A G. Subtractive immunization: a tool for the generation of discriminatory antibodies to proteins of similar sequence[J]. Immunol Methods, 2002,261:213-220.
  • 5Zijlstra A, Testa J E, Quigley J P. Targeting the proteome/epitome, implementation of subtractive immunization[J]. Biochem Biophys Res Commun, 2003,303:733-744.
  • 6Holbrook F L, Nicholson I C, Zola H. Tolerization as a tool for generating novel monoclonal antibodies[J]. Immunol Cell Biol, 2002, 80:319-322.
  • 7Janeway C A, Travers P. Immunobiology: the immune system in health and disease[M]. New York: Garland Publishing, 1997.
  • 8Lebron J A, Shen H, Bjorkman P J, et al. Tolerization of adult miee to immunodominant proteins before monoclonal antibody production[J]. J Immunol Methods, 1999,222:59-63.
  • 9Krueger P, Nitz C, Moore J, et al. Monoclonal antibody identifies a distinctive epitope expressed by human multiple myeloma cells[J]. J Immunother, 2001,24:334-344.
  • 10W.E.保罗,吴玉章.基础免疫学[M].北京:科学技术出版社,2003.25-2672.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部